Pharmacokinetic and pharmacodynamic single dose study of sitagliptin in healthy Indian male subjects

Trial Profile

Pharmacokinetic and pharmacodynamic single dose study of sitagliptin in healthy Indian male subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Mar 2018

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 06 Mar 2018 Results assessing PK/PD profile of single-dose sitagliptin 100 mg (Januvia) in healthy Indian male and also compared with non-Indian population, presented in the European Journal of Clinical Pharmacology.
    • 18 Jul 2017 New trial record
    • 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top